Dashtarzheneh A, Afrashtehpour A, Ramesh B, Loizidou M
In Vitro Model. 2025; 1(6):437-446.
PMID: 39872615
PMC: 11756458.
DOI: 10.1007/s44164-022-00033-w.
Mysior M, Simpson J
PLoS One. 2024; 19(11):e0311963.
PMID: 39531451
PMC: 11556727.
DOI: 10.1371/journal.pone.0311963.
Wu Y, Li X, Liu H, Yang X, Li R, Zhao H
Int J Oral Sci. 2024; 16(1):61.
PMID: 39482304
PMC: 11528035.
DOI: 10.1038/s41368-024-00324-w.
Phour J, Vassella E
Biol Methods Protoc. 2024; 9(1):bpae060.
PMID: 39234439
PMC: 11374025.
DOI: 10.1093/biomethods/bpae060.
Sonfack D, Tanguay Boivin C, Touzel Deschenes L, Maurand T, Maguemoun C, Berthod F
Bioengineering (Basel). 2024; 11(8).
PMID: 39199784
PMC: 11352167.
DOI: 10.3390/bioengineering11080826.
Regulation of cell fate by cell imprinting approach in vitro.
Hasannejad F, Montazeri L, Mano J, Bonakdar S, Fazilat A
Bioimpacts. 2024; 14(3):29945.
PMID: 38938752
PMC: 11199935.
DOI: 10.34172/bi.2023.29945.
Three-Dimensional Hepatocyte Spheroids: Model for Assessing Chemotherapy in Hepatocellular Carcinoma.
Royo F, Garcia-Vallicrosa C, Azparren-Angulo M, Bordanaba-Florit G, Lopez-Sarrio S, Falcon-Perez J
Biomedicines. 2024; 12(6).
PMID: 38927406
PMC: 11201042.
DOI: 10.3390/biomedicines12061200.
The importance of 3D fibre architecture in cancer and implications for biomaterial model design.
Ashworth J, Cox T
Nat Rev Cancer. 2024; 24(7):461-479.
PMID: 38886573
DOI: 10.1038/s41568-024-00704-8.
Fluid-Dynamic Culture of Tumour and Immune Cells for More Predictive Infiltration Studies and Immunotherapy Drug Screening.
Palama M, Aiello M, Scaglione S
Methods Mol Biol. 2024; 2782:147-157.
PMID: 38622399
DOI: 10.1007/978-1-0716-3754-8_11.
The progressive trend of modeling and drug screening systems of breast cancer bone metastasis.
Kolahi Azar H, Gharibshahian M, Rostami M, Mansouri V, Sabouri L, Beheshtizadeh N
J Biol Eng. 2024; 18(1):14.
PMID: 38317174
PMC: 10845631.
DOI: 10.1186/s13036-024-00408-5.
Naphthoquinone Derivatives from CF-097565 Display Anti-Tumour Activity in 3D Cultures of Breast Cancer Cells.
Mackenzie T, Reyes F, Martinez M, Gonzalez-Menendez V, Sanchez I, Genilloud O
Molecules. 2024; 29(2).
PMID: 38257340
PMC: 10820301.
DOI: 10.3390/molecules29020425.
In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced.
Arutyunyan I, Jumaniyazova E, Makarov A, Fatkhudinov T
J Pers Med. 2023; 13(11).
PMID: 38003890
PMC: 10672510.
DOI: 10.3390/jpm13111575.
Microsphere-Enabled Modular Formation of Miniaturized In Vitro Breast Cancer Models.
Wang W, Zhang L, ODell R, Yin Z, Yu D, Chen H
Small. 2023; 20(17):e2307365.
PMID: 37990372
PMC: 11045325.
DOI: 10.1002/smll.202307365.
Breast cancer organoids and their applications for precision cancer immunotherapy.
Guan D, Liu X, Shi Q, He B, Zheng C, Meng X
World J Surg Oncol. 2023; 21(1):343.
PMID: 37884976
PMC: 10601270.
DOI: 10.1186/s12957-023-03231-2.
Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics.
Farouk S, Khafaga A, Abdellatif A
Cancer Cell Int. 2023; 23(1):251.
PMID: 37880676
PMC: 10601189.
DOI: 10.1186/s12935-023-03069-4.
Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid-Based 3D In Vitro Models.
Landon-Brace N, Li N, McGuigan A
Adv Healthc Mater. 2023; 12(26):e2300903.
PMID: 37589373
PMC: 11468421.
DOI: 10.1002/adhm.202300903.
Organ Chips and Visualization of Biological Systems.
Tian T, Liu J, Zhu H
Adv Exp Med Biol. 2023; 1199:155-183.
PMID: 37460731
DOI: 10.1007/978-981-32-9902-3_8.
Breast cancer brain metastasis: from etiology to state-of-the-art modeling.
Farahani M, Gharibshahian M, Rezvani A, Vaez A
J Biol Eng. 2023; 17(1):41.
PMID: 37386445
PMC: 10311757.
DOI: 10.1186/s13036-023-00352-w.
Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Dzaman K, Czerwaty K
Pharmaceutics. 2023; 15(5).
PMID: 37242569
PMC: 10223025.
DOI: 10.3390/pharmaceutics15051327.
3D cancer models: One step closer to human studies.
Manduca N, Maccafeo E, De Maria R, Sistigu A, Musella M
Front Immunol. 2023; 14:1175503.
PMID: 37114038
PMC: 10126361.
DOI: 10.3389/fimmu.2023.1175503.